Your browser doesn't support javascript.
loading
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A.
Takeyama, Masahiro; Matsumoto, Naoki; Abe, Hiroto; Harada, Suguru; Ogiwara, Kenichi; Furukawa, Shoko; Shimonishi, Naruto; Nakajima, Yuto; Yada, Koji; Soeda, Tetsuhiro; Nogami, Keiji.
  • Takeyama M; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Matsumoto N; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan.
  • Abe H; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan.
  • Harada S; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan.
  • Ogiwara K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Furukawa S; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Shimonishi N; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Nakajima Y; The Course of Thrombosis and Hemostasis Molecular Pathology, Nara Medical University, Kashihara, Nara, Japan.
  • Yada K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Soeda T; Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Nara, Japan.
  • Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Pediatr Blood Cancer ; 70(10): e30590, 2023 10.
Article en En | MEDLINE | ID: mdl-37467119

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Hemofilia A Límite: Child, preschool / Humans / Infant Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Hemofilia A Límite: Child, preschool / Humans / Infant Idioma: En Año: 2023 Tipo del documento: Article